Letter from Patti Mattox Bryant to F. W. and Mildred Mattox

Letter from Patti Mattox Bryant to her parents, F. W. and Mildred Mattox, dated 11 August 1960. Patti writes to her parents about her memories of her recently deceased grandfather

Rees Odeil and Patti Mattox Bryant Papers, (1957-2007)

Finding aid for the Rees Odeil and Patti Mattox Bryant Papers, (1957-2007)

Finding aid for Rees Odeil and Patti Mattox Bryant Papers

Finding aid for the Rees Odeil and Patti Mattox Bryant Papers

\u3ci\u3eNewsletter No. 3\u3c/i\u3e

Newsletter No. 3 from Rees and Patti Bryant dated 1 May 1958. In the newsletter the Bryants write about the ministry opportunities they had during the month of April

Mark Garland in a Senior Voice Recital

This is the program for the senior voice recital of baritone, Mark Garland, accompanied by Patti Bryant on piano. The recital was held on October 22, 1990

Patti Vandiver Brayant in a Senior Voice Recital

This is the program for the senior voice recital of mezzo-soprano, Patti Vandiver Bryant, accompanied by Mary Worthen on piano. The recital was held on September 6, 1990, in the Mabee Fine Arts Center Recital Hall

Christopher R. Pauley in a Senior Recital

This is the program for the senior voice recital of Christopher R. Pauley, accompanied by Patti Bryant on piano and Cynthia Miles on the French horn. The recital was held on March 20, 1990, in the Mabee Fine Arts Center Recital Hall

Shree Varleta and Jody Hurst in a Senior Recital

This is the program for the senior voice recitals of mezzo-soprano, Sheree Varleta, accompanied by Keri Wood, pianist, and tenor, Jody Hurst, accompanied by Patti Bryant, pianist. The recital was held on March 27, 1990, in the Mabee Fine Arts Center Recital Hall

The contribution of risk factors to the effect of early otitis media with effusion on later language, reading, and spelling

Contains fulltext : 25015___.PDF (publisher's version ) (Open Access

Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In Vivo

A human donor-selected immunoglobulin G for intravenous injection (IGIV) product with elevated titers against the staphylococcal fibrinogen-binding MSCRAMM proteins ClfA and SdrG (INH-A21) was tested in vitro and in vivo. INH-A21 contained a significantly increased ability to inhibit the fibrinogen-binding activity of recombinant forms of both ClfA and SdrG. Evaluation of the opsonizing potential of INH-A21 was evaluated using fluorescently labeled bacteria; this assay indicated an increase in phagocytic activity compared to normal IGIV. The prophylactic efficacy of INH-A21 against an intraperitoneal challenge of methicillin-resistant Staphylococcus epidermidis (MRSE) was evaluated in a neonatal rat model. INH-A21 was also evaluated for prophylactic and therapeutic efficacy in a rabbit model of catheter-induced aortic valve infective endocarditis caused by either MRSE or methicillin-resistant Staphylococcus aureus (MRSA). Results from the in vivo models demonstrated potent prophylactic and therapeutic efficacy against both MRSE and MRSA. These data suggest that INH-A21 may be an important tool for the prevention and treatment of staphylococcal infections, especially in high-risk populations